M1000907 is a selective 5-HT2A receptor antagonist. It may interfere with altered 5-HT2A receptor signaling that contributes to ASD symptoms. Increased 5-HT2A receptor activity in certain brain regions may contribute to repetitive behaviors, so treatment with a selective 5-HT2A receptor antagonist has been proposed to improve cognitive flexibility in individuals with ASD.
